Stromal Cell-Derived Factor-1β Mediates Cell Survival through Enhancing Autophagy in Bone Marrow-Derived Mesenchymal Stem Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Herberg, Samuel ^a,b   Shi, Xingming ^b,c   Johnson, Maribeth H ^c   Hamrick, Mark W ^b,c   Isales, Carlos M ^b,c   Hill, William D ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c AUGUSTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; CASPASE 3; DOXYCYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STROMAL CELL DERIVED FACTOR 1BETA; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, MOUSE; HYDROGEN PEROXIDE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; BONE MARROW CELL; CELL LOSS; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL TRANSPLANTATION; CYTOLOGY; MALE; MESENCHYMAL STROMA CELL; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; AUTOPHAGY; BONE MARROW CELLS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMOKINE CXCL12; DOXYCYCLINE; HYDROGEN PEROXIDE; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84874590526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058207     Document Type: Article

References (47)

1. Caplan AI, (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217: 318-324.
2. Korbling M, Estrov Z, (2003) Adult stem cells for tissue repair- a new therapeutic concept? New England Journal of Medicine 349: 570-582.
3. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, et al. (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Engineering 13: 947-955.
4. Hou Z, Nguyen Q, Frenkel B, Nilsson SK, Milne M, et al. (1999) Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proceedings of the National Academy of Sciences of the United States of America 96: 7294-7299.
5. Nilsson SK, Dooner MS, Weier HU, Frenkel B, Lian JB, et al. (1999) Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. Journal of Experimental Medicine 189: 729-734.
6. Pereira RF, O'Hara MD, Laptev AV, Halford KW, Pollard MD, et al. (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proceedings of the National Academy of Sciences of the United States of America 95: 1142-1147.
7. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, et al. (2004) Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America 101: 11761-11766.
8. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, et al. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99: 8932-8937.
9. Danial NN, Korsmeyer SJ, (2004) Cell death: critical control points. Cell 116: 205-219.
10. Green DR, (2005) Apoptotic pathways: ten minutes to dead. Cell 121: 671-674.
11. Shintani T, Klionsky DJ, (2004) Autophagy in health and disease: a double-edged sword. Science 306: 990-995.
12. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ, (2007) Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6: 304-312.
13. Kroemer G, Levine B, (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9: 1004-1010.
14. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, et al. (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35: 233-245.
15. Liu X, Duan B, Cheng Z, Jia X, Mao L, et al. (2011) SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2: 845-854.
16. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, et al. (2005) Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105: 3793-3801.
17. Suzuki Y, Rahman M, Mitsuya H, (2001) Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 167: 3064-3073.
18. Teicher BA, Fricker SP, (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931.
19. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, et al. (2002) Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99: 1117-1129.
20. Broxmeyer HE, Kohli L, Kim CH, Lee Y, Mantel C, et al. (2003) Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73: 630-638.
21. Lee Y, Jung J, Cho KJ, Lee SK, Park JW, et al. (2012) Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem.
22. Oliver L, Hue E, Priault M, Vallette FM, (2012) Basal autophagy decreased during the differentiation of human adult mesenchymal stem cells. Stem Cells Dev 21: 2779-2788.
23. Zhang Q, Yang YJ, Wang H, Dong QT, Wang TJ, et al. (2012) Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev 21: 1321-1332.
24. Herberg S, Fulzele S, Yang N, Shi X, Hess M, et al. (2013) Stromal cell-derived factor-1beta potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A 19: 1-13.
25. Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, et al. (2005) Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 105: 4561-4568.
26. De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, et al. (2004) Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 103: 2452-2459.
27. Marquez-Curtis L, Jalili A, Deiteren K, Shirvaikar N, Lambeir AM, et al. (2008) Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization? Stem Cells 26: 1211-1220.
28. Zhang W, Ou G, Hamrick M, Hill W, Borke J, et al. (2008) Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. Journal of Bone and Mineral Research 23: 1118-1128.
29. Zhang W, Yang N, Shi XM, (2008) Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). Journal of Biological Chemistry 283: 4723-4729.
30. Ory DS, Neugeboren BA, Mulligan RC, (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proceedings of the National Academy of Sciences of the United States of America 93: 11400-11406.
31. Gossen M, Bujard H, (2002) Studying gene function in eukaryotes by conditional gene inactivation. Annual Review of Genetics 36: 153-173.
32. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201.
33. Xu R, Chen J, Cong X, Hu S, Chen X, (2008) Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. J Cell Biochem 103: 256-269.
34. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, et al. (2008) Fibroblast growth factor-2 and-4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 17: 725-736.
35. Zhang J, Cai H, (2010) Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J Mol Cell Cardiol 48: 1060-1070.
36. Fernandes-Alnemri T, Litwack G, Alnemri ES, (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764.
37. Porter AG, Janicke RU, (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104.
38. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G, (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8: 741-752.
39. Tanida I, Ueno T, Kominami E, (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36: 2503-2518.
40. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, et al. (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 26: 2527-2539.
41. Kessel D, Reiners JJ Jr, (2007) Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett 249: 294-299.
42. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, et al. (2004) Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-4293.
43. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, et al. (2007) Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14: 146-157.
44. Oberstein A, Jeffrey PD, Shi Y, (2007) Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282: 13123-13132.
45. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, et al. (2007) BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3: 374-376.
46. Nobukuni T, Kozma SC, Thomas G, (2007) hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling. Curr Opin Cell Biol 19: 135-141.
47. Lipinski MM, Hoffman G, Ng A, Zhou W, Py BF, et al. (2010) A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell 18: 1041-1052.